Vertex Pharmaceuticals (VRTX)

CapEx to Revenue

3.37%

Quarterly · Period ending:

VRTX logo

VRTX CapEx to Revenue

Latest reported3.37%
VRTX Quarterly CapEx/Revenue (0.00% → 3.37%)
High-resolution chart · PNG

VRTX capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
47.3674%
52.7155%
29.4915%
12.0438%
4.801%
35.2785%
9.1216%
59.375%
34.6405%
62.5%
18.8034%
6.5217%
31.9444%
68.75%
16.9643%
8.1481%
5.7377%
33.3333%
47.9167%
20.6897%
16.129%
24%
45.122%
30.4348%
7.6923%
9.8039%
14.8148%
4.6154%
2.0833%
23.2143%
1.6667%
9.0909%
2.1739%
133.3333%
120%
40%
20%
100%
75%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.